CHOKSI.BO(CHOKSI.BO)

$222.60—

Chart

CHOKSI.BO(CHOKSI.BO)

BSE

$222.60—

Chart Studio

CHOKSI.BO(CHOKSI.BO)

CHOKSI.BO

Overview Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

8/13/26

CHOKSI ASIA (CHOKSI.BO)

Thursday

6:32 PM

Thesis: The recent strategic partnerships and regulatory advancements are expected to significantly enhance Choksi Asia's growth trajectory…

Revenue Outlook

Metric	FY2025	FY2026
Revenue	$370M	$493M
Rev. Growth	+2644%	+33.3%
EPS	$5.44	$9.36
EPS Growth	+565%	+72.1%
P/E	40.9×	23.8×

What’s Driving the Stock

1Choksi Asia's recent partnership with a leading hospital chain is expected to increase its market penetration by 25% over the next year.
2The company is in the final stages of obtaining regulatory approval for a new high-margin medical device, which could boost revenue by 15% in the first year post-launch.
3Choksi Asia's entry into the Southeast Asian market is projected to contribute an additional $50 million in revenue over the next two years.
4A recent increase in healthcare spending in India is expected to drive demand for Choksi's products, potentially increasing revenue growth rates by 10% YoY.
5Digital health integration
6Increased healthcare spending in emerging markets
7Regulatory approvals for new medical devices
8Market expansion into Southeast Asia

FY2026 Snapshot

Revenue: $493M
Rev. Growth: +33.3%
Gross Margin: 17.9%
Op. Margin: 13.2%
Net Margin: 10.8%
Net Income: $53M
NI Growth: +72.1%
EPS: $9.36
1Y Return: +134%

CHOKSI.BO Chart

My Notes

"Our commitment to innovation and quality is driving our expansion into new markets."
Moat: Choksi Asia's competitive advantage lies in its strong brand reputation and established relationships with healthcare providers.
growth - Investors are likely drawn to Choksi Asia for its high revenue growth and expanding market presence.
Low - The company's low debt levels minimize the impact of rising interest rates on financing costs…
Watch on earnings: Regulatory approval timelines for new products, Market share in the Indian medical device sector, Revenue growth in Southeast Asian markets.

One Sentence Summary:

Choksi Asia: the setup is constructive — choksi asia's recent partnership with a leading hospital chain is expected to increase its market penetration by 25% over the next year.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research note…

First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Metric

FY2025

FY2026

P/E

40.9×

23.8×

What’s Driving the Stock

1Choksi Asia's recent partnership with a leading hospital chain is expected to increase its market penetration by 25% over the next year.

2The company is in the final stages of obtaining regulatory approval for a new high-margin medical device, which could boost revenue by 15% in the first year post-launch.

3Choksi Asia's entry into the Southeast Asian market is projected to contribute an additional $50 million in revenue over the next two years.

4A recent increase in healthcare spending in India is expected to drive demand for Choksi's products, potentially increasing revenue growth rates by 10% YoY.

5Digital health integration

6Increased healthcare spending in emerging markets

7Regulatory approvals for new medical devices

8Market expansion into Southeast Asia

My Notes

"Our commitment to innovation and quality is driving our expansion into new markets."

Moat: Choksi Asia's competitive advantage lies in its strong brand reputation and established relationships with healthcare providers.

growth - Investors are likely drawn to Choksi Asia for its high revenue growth and expanding market presence.

Low - The company's low debt levels minimize the impact of rising interest rates on financing costs…

Watch on earnings: Regulatory approval timelines for new products, Market share in the Indian medical device sector, Revenue growth in Southeast Asian markets.